Stuart Anderson
Independent Non-Executive Board Member
biomedicine
Cerep (Eurofins)
China
Biography
Stuart Anderson is the Independent Non-Executive Board Member of the Eurofins Scientific Group.Over the past 12 years, Cerep has developed BioPrint®, a unique database and related IT tools, which allows the modeling of clinical effects of drug candidates from their molecular properties. BioPrint® may be used to interpret complex profiling data, prioritize lead or drug candidates or design lead optimization profiles. In 2010 Cerep has established a laboratory in Shanghai which is now fully operational to effectively support drug discovery projects that are run in Asia by providing the same high quality data that made Cerep’s reputation in the market.
Research Interest
biomedicine